Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,836
archived clinical trials in
Leukemia

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Dodge City
925
mi
from 43215
Dodge City, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Dodge City
925
mi
from 43215
Dodge City, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas - Fort Scott
646
mi
from 43215
Fort Scott, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas - Fort Scott
646
mi
from 43215
Fort Scott, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas-Independence
711
mi
from 43215
Independence, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas-Independence
711
mi
from 43215
Independence, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Kingman
827
mi
from 43215
Kingman, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Kingman
827
mi
from 43215
Kingman, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Lawrence Memorial Hospital
654
mi
from 43215
Lawrence, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Lawrence Memorial Hospital
654
mi
from 43215
Lawrence, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Liberal
988
mi
from 43215
Liberal, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Liberal
988
mi
from 43215
Liberal, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Newton
778
mi
from 43215
Newton, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Newton
778
mi
from 43215
Newton, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Parsons
683
mi
from 43215
Parsons, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Parsons
683
mi
from 43215
Parsons, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Pratt
860
mi
from 43215
Pratt, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Pratt
860
mi
from 43215
Pratt, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Salina
782
mi
from 43215
Salina, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Salina
782
mi
from 43215
Salina, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Wellington
797
mi
from 43215
Wellington, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wellington
797
mi
from 43215
Wellington, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Wichita
783
mi
from 43215
Wichita, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Wichita
783
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Wesley Medical Center
784
mi
from 43215
Wichita, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Wesley Medical Center
784
mi
from 43215
Wichita, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Winfield
775
mi
from 43215
Winfield, KA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Winfield
775
mi
from 43215
Winfield, KA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Hurley Medical Center
213
mi
from 43215
Flint, MI
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Hurley Medical Center
213
mi
from 43215
Flint, MI
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Glacier Oncology, PLLC
1640
mi
from 43215
Kalispell, MT
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Glacier Oncology, PLLC
1640
mi
from 43215
Kalispell, MT
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Kalispell Regional Medical Center
1640
mi
from 43215
Kalispell, MT
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Kalispell Regional Medical Center
1640
mi
from 43215
Kalispell, MT
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of New Mexico Cancer Center
1332
mi
from 43215
Albuquerque, NM
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of New Mexico Cancer Center
1332
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Ben Taub General Hospital
995
mi
from 43215
Houston, TX
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Ben Taub General Hospital
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Harborview Medical Center
2006
mi
from 43215
Seattle, WA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Harborview Medical Center
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Minor and James Medical, PLLC
2006
mi
from 43215
Seattle, WA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Minor and James Medical, PLLC
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Care Northwest - Spokane South
1777
mi
from 43215
Spokane, WA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Care Northwest - Spokane South
1777
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Evergreen Hematology and Oncology, PS
1778
mi
from 43215
Spokane, WA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Evergreen Hematology and Oncology, PS
1778
mi
from 43215
Spokane, WA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Oncology
1217
mi
from 43215
Casper, WY
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Oncology
1217
mi
from 43215
Casper, WY
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham Cancer Center
492
mi
from 43215
Birmingham, AL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham Cancer Center
492
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
624
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Stanford Cancer Institute
2102
mi
from 43215
Palo Alto, CA
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Stanford Cancer Institute
2102
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
1154
mi
from 43215
Aurora, CO
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Cancer Center - Anschutz Cancer Pavilion
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
553
mi
from 43215
Hartford, CT
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Smilow Cancer Hospital Care Center at Saint Francis
553
mi
from 43215
Hartford, CT
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Moffitt Cancer Center
823
mi
from 43215
Tampa, FL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Moffitt Cancer Center
823
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Cancer Care Center-Boise
1715
mi
from 43215
Boise, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Boise
1715
mi
from 43215
Boise, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
1738
mi
from 43215
Caldwell, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
1738
mi
from 43215
Caldwell, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Kootenai Medical Center
1748
mi
from 43215
Coeur d'Alene, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Kootenai Medical Center
1748
mi
from 43215
Coeur d'Alene, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Walter Knox Memorial Hospital
1729
mi
from 43215
Emmett, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Walter Knox Memorial Hospital
1729
mi
from 43215
Emmett, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Idaho Urologic Institute - Meridian
1725
mi
from 43215
Meridian, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Idaho Urologic Institute - Meridian
1725
mi
from 43215
Meridian, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Saint Alphonsus Medical Center-Nampa
1734
mi
from 43215
Nampa, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
1734
mi
from 43215
Nampa, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Kootenai Cancer Center
1757
mi
from 43215
Post Falls, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Kootenai Cancer Center
1757
mi
from 43215
Post Falls, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Kootenai Cancer Clinic
1742
mi
from 43215
Sandpoint, ID
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Kootenai Cancer Clinic
1742
mi
from 43215
Sandpoint, ID
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Saint Joseph Medical Center
314
mi
from 43215
Bloomington, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Saint Joseph Medical Center
314
mi
from 43215
Bloomington, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Bloomington
314
mi
from 43215
Bloomington, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Bloomington
314
mi
from 43215
Bloomington, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Canton
371
mi
from 43215
Canton, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Canton
371
mi
from 43215
Canton, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital of Carbondale
367
mi
from 43215
Carbondale, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital of Carbondale
367
mi
from 43215
Carbondale, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
SIH Cancer Institute
359
mi
from 43215
Carterville, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
SIH Cancer Institute
359
mi
from 43215
Carterville, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Carthage
428
mi
from 43215
Carthage, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Carthage
428
mi
from 43215
Carthage, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Centralia Oncology Clinic
341
mi
from 43215
Centralia, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Centralia Oncology Clinic
341
mi
from 43215
Centralia, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Cancer Care Center of Decatur
314
mi
from 43215
Decatur, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Cancer Care Center of Decatur
314
mi
from 43215
Decatur, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Decatur Memorial Hospital
314
mi
from 43215
Decatur, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Decatur Memorial Hospital
314
mi
from 43215
Decatur, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Crossroads Cancer Center
300
mi
from 43215
Effingham, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Crossroads Cancer Center
300
mi
from 43215
Effingham, IL
Click here to add this to my saved trials
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Eureka
333
mi
from 43215
Eureka, IL
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
S0919, A Phase II Study of Idarubicin and Ara-C in Combination With Pravastatin for Relapsed Acute Myelogenous Leukemia (AML)
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Eureka
333
mi
from 43215
Eureka, IL
Click here to add this to my saved trials